WealthInsights ""Van Lanschot Private Banking : Company Profile and SWOT Analysis"" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key employees, company locations and subsidiaries as well as employee biographies.
This report is a crucial resource for industry executives and anyone looking to access key information about ""Van Lanschot Private Banking""
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. WealthInsight strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
• Examines and identifies key information and issues about ""Van Lanschot Private Banking"" for business intelligence requirements.
• Studies and presents the companys strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.
Reasons To Buy
• Quickly enhance your understanding of ""Van Lanschot Private Banking""
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.
Van Lanschot Private Banking is the private banking and wealth management arm of Van Lanschot NV, which is the holding company of F. van Lanschot Bankiers NV, one of the oldest independent banks in the Netherlands. The company offers a broad range of private banking and wealth management services to high-net-worth-individuals (HNWIs have net worth of US$1 million or more, excluding their primary residence) and their families. Key services offered by the company include wealth structuring, tax optimization, asset management, investment advisory, execution only, and financing solutions. Under the Van Lanschot Kempen brand, the bank focuses on clients with EUR5.0 million in investable assets. The company has operations across 26 locations in the Netherlands. It also has a presence in Belgium and Switzerland. Van Lanschot Private Banking is headquartered in s-Hertogenbosch, the Netherlands.
1 Van Lanschot Private Banking - Business Analysis
1.1 Van Lanschot Private Banking - Company Overview
1.2 Van Lanschot Private Banking - Business Description
1.3 Van Lanschot Private Banking - Major Products and Services
2 Van Lanschot Private Banking - SWOT Analysis
2.1 Van Lanschot Private Banking - SWOT Analysis - Overview
2.2 Van Lanschot Private Banking - Strengths
2.3 Van Lanschot Private Banking - Weaknesses
2.4 Van Lanschot Private Banking - Opportunities
2.5 Van Lanschot Private Banking - Threats
3 Van Lanschot Private Banking - Company Statement
4 Van Lanschot Private Banking - History
5 Van Lanschot Private Banking - Key Employees
6 Van Lanschot Private Banking - Key Employee Biographies
7 Van Lanschot Private Banking - Locations and Subsidiaries
7.1 Van Lanschot Private Banking - Head Office
7.2 Van Lanschot Private Banking - Other Locations and Subsidiaries
List Of Tables
Table 1: Van Lanschot Private Banking - Major Products and Services
Table 2: Van Lanschot Private Banking - History
Table 3: Van Lanschot Private Banking - Key Employees
Table 4: Van Lanschot Private Banking - Key Employee Biographies
Table 5: Van Lanschot Private Banking - Subsidiaries
Table 6: Van Lanschot Private Banking - Locations
Sun Pharma Advanced Research Company Ltd (SPARC) a subsidiary of Sun Pharmaceutical Industries Ltd is a pharmaceutical company that conducts research and and produces drugs. The company develops APIs, formulations
Theravance Biopharma Inc (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The companys pipeline programs include Revefenacin (TD-4208),
Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in
Van Lanschot NV Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT
USD 200View Report
PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)
|Published Date||:||Jun 2015|
|No. of Pages||:||17|
|Category||:||Finance and Banking|
|Report Delivery By||:|
|Report Delivery Time||:||12 to 24 hours after placing the order.|
If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE